Leptin receptor 170 kDa (OB-R170) protein expression is reduced in obese human skeletal muscle: A potential mechanism of leptin resistance

Experimental Physiology

Volumn 95, Issue 1, 2010, Pages 160-171

  Fuentes, T ^a   Ara, I ^b,c   Guadalupe Grau, A ^a   Larsen, S ^c   Stallknecht, B ^c   Olmedillas, H ^a   Santana, A ^a,d,e   Helge, J W ^c   Calbet, J A L ^a   Guerra, B ^a  

^a UNIVERSITY OF LAS PALMAS DE GRAN CANARIA   (Spain)

^b UNIVERSITY OF ZARAGOZA   (Spain)

^c UNIVERSITY OF COPENHAGEN   (Denmark)

^d HOSPITAL UNIVERSITARIO MATERNO INFANTIL DE CANARIAS   (Spain)

^e HOSPITAL UNIVERSITARIO DE GRAN CANARIA DR NEGRÍN   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYL COENZYME A; ACETYL COENZYME A CARBOXYLASE; ACETYL COENZYME A CARBOXYLASE BETA; ADENOSINE PHOSPHATE ACTIVATED PROTEIN KINASE ALPHA; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; JANUS KINASE 2; LEPTIN; LEPTIN RECEPTOR; LEPTIN RECEPTOR 170 KDA; PROTEIN TYROSINE PHOSPHATASE 1B; STAT3 PROTEIN; SUPPRESSOR OF CYTOKINE SIGNALING 3; UNCLASSIFIED DRUG;

ADULT; ARM MUSCLE; ARTICLE; BODY FAT; BODY HEIGHT; BODY MASS; BODY WEIGHT; CLINICAL ARTICLE; CONTROLLED STUDY; DELTOID MUSCLE; HUMAN; LEG MUSCLE; MALE; MUSCLE BIOPSY; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; RECEPTOR DOWN REGULATION; RECEPTOR UPREGULATION; REGULATORY MECHANISM; SIGNAL TRANSDUCTION; SKELETAL MUSCLE; VASTUS LATERALIS MUSCLE;

EID: 74049113378     PISSN: 09580670     EISSN: 1469445X     Source Type: Journal    
DOI: 10.1113/expphysiol.2009.049270     Document Type: Article

References (56)

1. Ahmad F, Azevedo JL, Cortright R, Dohm GL Goldstein BJ (1997a). Alterations in skeletal muscle protein-tyrosine phosphatase activity and expression in insulin-resistant human obesity and diabetes. J Clin Invest 100, 449 458.
2. Ahmad F, Considine RV, Bauer TL, Ohannesian JP, Marco CC Goldstein BJ (1997b). Improved sensitivity to insulin in obese subjects following weight loss is accompanied by reduced protein-tyrosine phosphatases in adipose tissue. Metabolism 46, 1140 1145.
3. Akasaka Y, Tsunoda M, Ide T Murakami K (2009). Chronic leptin treatment stimulates lipid oxidation in immortalized and primary mouse skeletal muscle cells. Biochim Biophys Acta 1791, 103 109.
4. Akira S (2000). Roles of STAT3 defined by tissue-specific gene targeting. Oncogene 19, 2607 2611.
5. Anubhuti Arora S (2008). Leptin and its metabolic interactions: an update. Diabetes Obes Metab 10, 973 993.
6. Aparicio T, Kermorgant S, Darmoul D, Guilmeau S, Hormi K, Mahieu-Caputo D Lehy T (2005). Leptin and Ob-Rb receptor isoform in the human digestive tract during fetal development. J Clin Endocrinol Metab 90, 6177 6184.
7. Bandyopadhyay GK, Yu JG, Ofrecio J Olefsky JM (2006). Increased malonyl-CoA levels in muscle from obese and type 2 diabetic subjects lead to decreased fatty acid oxidation and increased lipogenesis; thiazolidinedione treatment reverses these defects. Diabetes 55, 2277 2285.
8. Banks AS, Davis SM, Bates SH Myers MG Jr. (2000). Activation of downstream signals by the long form of the leptin receptor. J Biol Chem 275, 14563 14572.
9. Bates SH Myers MG Jr. (2003). The role of leptin receptor signaling in feeding and neuroendocrine function. Trends Endocrinol Metab 14, 447 452.
10. Bates SH, Stearns WH, Dundon TA, Schubert M, Tso AW, Wang Y, Banks AS, Lavery HJ, Haq AK, Maratos-Flier E, Neel BG, Schwartz MW Myers MG Jr. (2003). STAT3 signalling is required for leptin regulation of energy balance but not reproduction. Nature 421, 856 859.
11. Bjørbæk C, El-Haschimi K, Frantz JD Flier JS (1999). The role of SOCS-3 in leptin signaling and leptin resistance. J Biol Chem 274, 30059 30065.
12. Bjørbæk C Kahn BB (2004). Leptin signaling in the central nervous system and the periphery. Recent Prog Horm Res 59, 305 331.
13. Bjørbæk C, Lavery HJ, Bates SH, Olson RK, Davis SM, Flier JS Myers MG Jr. (2000). SOCS3 mediates feedback inhibition of the leptin receptor via Tyr985. J Biol Chem 275, 40649 40657.
14. Calbet JA, Holmberg HC, Rosdahl H, van Hall G, Jensen-Urstad M Saltin B (2005). Why do arms extract less oxygen than legs during exercise? Am J Physiol Regul Integr Comp Physiol 289, R1448 R1458.
15. Chan JL, Bluher S, Yiannakouris N, Suchard MA, Kratzsch J Mantzoros CS (2002). Regulation of circulating soluble leptin receptor levels by gender, adiposity, sex steroids, and leptin: observational and interventional studies in humans. Diabetes 51, 2105 2112.
16. Chen YW, Gregory CM, Scarborough MT, Shi R, Walter GA Vandenborne K (2007). Transcriptional pathways associated with skeletal muscle disuse atrophy in humans. Physiol Genomics 31, 510 520.
17. Cheung A, Kusari J, Jansen D, Bandyopadhyay D, Kusari A Bryer-Ash M (1999). Marked impairment of protein tyrosine phosphatase 1B activity in adipose tissue of obese subjects with and without type 2 diabetes mellitus. J Lab Clin Med 134, 115 123.
18. Dube N Tremblay ML (2005). Involvement of the small protein tyrosine phosphatases TC-PTP and PTP1B in signal transduction and diseases: from diabetes, obesity to cell cycle, and cancer. Biochim Biophys Acta 1754, 108 117.
19. Eguchi M, Gillis LC, Liu Y, Lyakhovsky N, Du M, McDermott JC Sweeney G (2007). Regulation of SOCS-3 expression by leptin and its co-localization with insulin receptor in rat skeletal muscle cells. Mol Cell Endocrinol 267, 38 45.
20. Guerra B, Fuentes T, Delgado-Guerra S, Guadalupe-Grau A, Olmedillas H, Santana A, Ponce-Gonzalez JG, Dorado C Calbet JA (2008). Gender dimorphism in skeletal muscle leptin receptors, serum leptin and insulin sensitivity. PLoS One 3, e3466.
21. Guerra B, Santana A, Fuentes T, Delgado-Guerra S, Cabrera-Socorro A, Dorado C Calbet JA (2007). Leptin receptors in human skeletal muscle. J Appl Physiol 102, 1786 1792.
22. Hikita M, Bujo H, Hirayama S, Takahashi K, Morisaki N Saito Y (2000). Differential regulation of leptin receptor expression by insulin and leptin in neuroblastoma cells. Biochem Biophys Res Commun 271, 703 709. (Pubitemid 30444692)
23. Hosoi T, Sasaki M, Miyahara T, Hashimoto C, Matsuo S, Yoshii M Ozawa K (2008). Endoplasmic reticulum stress induces leptin resistance. Mol Pharmacol 74, 1610 1619.
24. Judd LM, Bredin K, Kalantzis A, Jenkins BJ, Ernst M Giraud AS (2006). STAT3 activation regulates growth, inflammation, and vascularization in a mouse model of gastric tumorigenesis. Gastroenterology 131, 1073 1085.
25. Kamikubo Y, Dellas C, Loskutoff DJ, Quigley JP Ruggeri ZM (2008). Contribution of leptin receptor N-linked glycans to leptin binding. Biochem J 410, 595 604.
26. Kusari J, Kenner KA, Suh KI, Hill DE Henry RR (1994). Skeletal muscle protein tyrosine phosphatase activity and tyrosine phosphatase 1B protein content are associated with insulin action and resistance. J Clin Invest 93, 1156 1162.
27. Laemmli UK (1970). Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227, 680 685.
28. Liu ZJ, Bian J, Liu J Endoh A (2007). Obesity reduced the gene expressions of leptin receptors in hypothalamus and liver. Horm Metab Res 39, 489 494.
29. Liu ZJ, Endoh A, Li R Ohzeki T (2004). Effects of leptin and dexamethasone on long and short leptin receptor mRNA. Pediatr Int 46, 561 564.
30. Lundby C, Sander M, van Hall G, Saltin B Calbet JA (2006). Determinants of maximal exercise and muscle oxygen extraction in acclimatizing lowlanders and in high altitude natives. J Physiol 573, 535 547.
31. Martin RL, Perez E, He YJ, Dawson R Jr. Millard WJ (2000). Leptin resistance is associated with hypothalamic leptin receptor mRNA and protein downregulation. Metabolism 49, 1479 1484.
32. Munzberg H, Bjornholm M, Bates SH Myers MG Jr. (2005). Leptin receptor action and mechanisms of leptin resistance. Cell Mol Life Sci 62, 642 652.
33. Murray PJ (2007). The JAK-STAT signaling pathway: input and output integration. J Immunol 178, 2623 2629.
34. Myers MG, Cowley MA Munzberg H (2008). Mechanisms of leptin action and leptin resistance. Annu Rev Physiol 70, 537 556.
35. Olefsky JM, Kolterman OG Scarlett JA (1982). Insulin action and resistance in obesity and noninsulin-dependent type II diabetes mellitus. Am J Physiol Endocrinol Metab 243, E15 E30.
36. Olsen DB, Sacchetti M, Dela F, Ploug T Saltin B (2005). Glucose clearance is higher in arm than leg muscle in type 2 diabetes. J Physiol 565, 555 562.
37. Ruderman NB, Saha AK, Vavvas D Witters LA (1999). Malonyl-CoA, fuel sensing, and insulin resistance. Am J Physiol Endocrinol Metab 276, E1 E18.
38. Smith PK, Krohn RI, Hermanson GT, Mallia AK, Gartner FH, Provenzano MD, Fujimoto EK, Goeke NM, Olson BJ Klenk DC (1985). Measurement of protein using bicinchoninic acid. Anal Biochem 150, 76 85.
39. Sørensen TI, Echwald S Holm JC (1996). Leptin in obesity. BMJ 313, 953 954.
40. Steinberg GR, Dyck DJ, Calles-Escandon J, Tandon NN, Luiken JJ, Glatz JF Bonen A (2002a). Chronic leptin administration decreases fatty acid uptake and fatty acid transporters in rat skeletal muscle. J Biol Chem 277, 8854 8860.
41. Steinberg GR Jorgensen SB (2007). The AMP-activated protein kinase: role in regulation of skeletal muscle metabolism and insulin sensitivity. Mini Rev Med Chem 7, 519 526.
42. Steinberg GR, McAinch AJ, Chen MB, O'Brien PE, Dixon JB, Cameron-Smith D Kemp BE (2006a). The suppressor of cytokine signaling 3 inhibits leptin activation of AMP-kinase in cultured skeletal muscle of obese humans. J Clin Endocrinol Metab 91, 3592 3597.
43. Steinberg GR, Macaulay SL, Febbraio MA Kemp BE (2006b). AMP-activated protein kinase - the fat controller of the energy railroad. Can J Physiol Pharmacol 84, 655 665.
44. Steinberg GR, Michell BJ, van Denderen BJ, Watt MJ, Carey AL, Fam BC, Andrikopoulos S, Proietto J, Gorgun CZ, Carling D, Hotamisligil GS, Febbraio MA, Kay TW Kemp BE (2006c). Tumor necrosis factor α-induced skeletal muscle insulin resistance involves suppression of AMP-kinase signaling. Cell Metab 4, 465 474.
45. Steinberg GR, Parolin ML, Heigenhauser GJ Dyck DJ (2002b). Leptin increases FA oxidation in lean but not obese human skeletal muscle: evidence of peripheral leptin resistance. Am J Physiol Endocrinol Metab 283, E187 E192.
46. Steinberg GR, Smith AC, Van Denderen BJ, Chen Z, Murthy S, Campbell DJ, Heigenhauser GJ, Dyck DJ Kemp BE (2004a). AMP-activated protein kinase is not down-regulated in human skeletal muscle of obese females. J Clin Endocrinol Metab 89, 4575 4580.
47. Steinberg GR, Smith AC, Wormald S, Malenfant P, Collier C Dyck DJ (2004b). Endurance training partially reverses dietary-induced leptin resistance in rodent skeletal muscle. Am J Physiol Endocrinol Metab 286, E57 E63.
48. Stepkowski SM, Chen W, Ross JA, Nagy ZS Kirken RA (2008). STAT3: an important regulator of multiple cytokine functions. Transplantation 85, 1372 1377.
49. Thampy KG (1989). Formation of malonyl coenzyme A in rat heart. Identification and purification of an isozyme of a carboxylase from rat heart. J Biol Chem 264, 17631 17634.
50. Towbin H, Staehelin T Gordon J (1979). Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc Natl Acad Sci USA 76, 4350 4354.
51. Wang Z, Zhou YT, Kakuma T, Lee Y, Kalra SP, Kalra PS, Pan W Unger RH (2000). Leptin resistance of adipocytes in obesity: role of suppressors of cytokine signaling. Biochem Biophys Res Commun 277, 20 26.
52. Wang ZW, Pan WT, Lee Y, Kakuma T, Zhou YT Unger RH (2001). The role of leptin resistance in the lipid abnormalities of aging. FASEB J 15, 108 114.
53. Worm D, Vinten J Beck-Nielsen H (1999). The significance of phosphotyrosine phosphatase (PTPase) 1B in insulin signalling. Diabetologia 42, 1146 1149.
54. Zabolotny JM, Bence-Hanulec KK, Stricker-Krongrad A, Haj F, Wang Y, Minokoshi Y, Kim YB, Elmquist JK, Tartaglia LA, Kahn BB Neel BG (2002). PTP1B regulates leptin signal transduction in vivo. Dev Cell 2, 489 495.
55. Zabolotny JM, Haj FG, Kim YB, Kim HJ, Shulman GI, Kim JK, Neel BG Kahn BB (2004). Transgenic overexpression of protein-tyrosine phosphatase 1B in muscle causes insulin resistance, but overexpression with leukocyte antigen-related phosphatase does not additively impair insulin action. J Biol Chem 279, 24844 24851.
56. Zabolotny JM, Kim YB, Welsh LA, Kershaw EE, Neel BG Kahn BB (2008). Protein-tyrosine phosphatase 1B expression is induced by inflammation in vivo. J Biol Chem 283, 14230 14241.